Moderna Inc (NAS:MRNA)
$ 43.39 1.34 (3.19%) Market Cap: 16.70 Bil Enterprise Value: 10.67 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 66/100

Moderna Inc at Piper Sandler Healthcare Conference Transcript

Dec 01, 2022 / 02:00PM GMT
Release Date Price: $181.48 (+3.17%)
Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Good morning, everyone. My name is Ted Tenthoff. I'm a senior biotech analyst at Piper Sandler. And before I begin, firstly, thank you all for joining us.

And before I begin, I am required to point out certain disclosures regarding the relationship between Piper and Moderna that are posted at the back of the room and also at the registration desk.

So I don't think Moderna needs much of an introduction these days. I remember when we first did the IPO, it took a little bit more, but now pretty much a household name, thanks to all of your hard work in protecting us against the COVID pandemic.

But what I really love about the story, I think it's just getting excited now, because you have a dramatically strengthened balance sheet and really a fundamentally derisked technology and are developing a pipeline of new mRNA vaccines and medicines that I think are even going to have a bigger impact.

I'm very pleased to have my good friend, Stephane Bancel. Thanks for taking the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot